187 related articles for article (PubMed ID: 28934252)
1. Three-way interaction model to trace the mechanisms involved in Alzheimer's disease transgenic mice.
Khayer N; Marashi SA; Mirzaie M; Goshadrou F
PLoS One; 2017; 12(9):e0184697. PubMed ID: 28934252
[TBL] [Abstract][Full Text] [Related]
2. Region-specific metabolic alterations in the brain of the APP/PS1 transgenic mice of Alzheimer's disease.
González-Domínguez R; García-Barrera T; Vitorica J; Gómez-Ariza JL
Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2395-402. PubMed ID: 25281826
[TBL] [Abstract][Full Text] [Related]
3. GFAP and vimentin deficiency alters gene expression in astrocytes and microglia in wild-type mice and changes the transcriptional response of reactive glia in mouse model for Alzheimer's disease.
Kamphuis W; Kooijman L; Orre M; Stassen O; Pekny M; Hol EM
Glia; 2015 Jun; 63(6):1036-56. PubMed ID: 25731615
[TBL] [Abstract][Full Text] [Related]
4. Self-assembling nanofibers alter the processing of amyloid precursor protein in a transgenic mouse model of Alzheimer's disease.
Yang H; Yang H; Xie Z; Wang P; Bi J
Neurol Res; 2015 Jan; 37(1):84-91. PubMed ID: 25005263
[TBL] [Abstract][Full Text] [Related]
5. Abeta deposition and related pathology in an APP x PS1 transgenic mouse model of Alzheimer's disease.
Howlett DR; Bowler K; Soden PE; Riddell D; Davis JB; Richardson JC; Burbidge SA; Gonzalez MI; Irving EA; Lawman A; Miglio G; Dawson EL; Howlett ER; Hussain I
Histol Histopathol; 2008 Jan; 23(1):67-76. PubMed ID: 17952859
[TBL] [Abstract][Full Text] [Related]
6. Gender difference in valproic acid-induced neuroprotective effects on APP/PS1 double transgenic mice modeling Alzheimer's disease.
Long Z; Zeng Q; Wang K; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2016 Oct; 48(10):930-938. PubMed ID: 27614317
[TBL] [Abstract][Full Text] [Related]
7. Gene Expression Profiling in the APP/PS1KI Mouse Model of Familial Alzheimer's Disease.
Weissmann R; Hüttenrauch M; Kacprowski T; Bouter Y; Pradier L; Bayer TA; Kuss AW; Wirths O
J Alzheimers Dis; 2016; 50(2):397-409. PubMed ID: 26639971
[TBL] [Abstract][Full Text] [Related]
8. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
[TBL] [Abstract][Full Text] [Related]
9. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
10. RT-DOb, a switch gene for the gene pair {Csf1r, Milr1}, can influence the onset of Alzheimer's disease by regulating communication between mast cell and microglia.
Khayer N; Motamed N; Marashi SA; Goshadrou F
PLoS One; 2023; 18(7):e0288134. PubMed ID: 37410787
[TBL] [Abstract][Full Text] [Related]
11. Interneurons and beta-amyloid in the olfactory bulb, anterior olfactory nucleus and olfactory tubercle in APPxPS1 transgenic mice model of Alzheimer's disease.
Saiz-Sanchez D; De La Rosa-Prieto C; Ubeda-Bañon I; Martinez-Marcos A
Anat Rec (Hoboken); 2013 Sep; 296(9):1413-23. PubMed ID: 23904197
[TBL] [Abstract][Full Text] [Related]
12. Distribution and expression of Pen-2 in the central nervous system of APP/PS1 double transgenic mice.
Chu Y; Peng X; Long Z; Wang K; Luo S; Sharma A; He G
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):258-66. PubMed ID: 25736404
[TBL] [Abstract][Full Text] [Related]
13. Age-dependent increment of hydroxymethylation in the brain cortex in the triple-transgenic mouse model of Alzheimer's disease.
Cadena-del-Castillo C; Valdes-Quezada C; Carmona-Aldana F; Arias C; Bermúdez-Rattoni F; Recillas-Targa F
J Alzheimers Dis; 2014; 41(3):845-54. PubMed ID: 24685633
[TBL] [Abstract][Full Text] [Related]
14. Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease.
Guo C; Wang T; Zheng W; Shan ZY; Teng WP; Wang ZY
Neurobiol Aging; 2013 Feb; 34(2):562-75. PubMed ID: 22717236
[TBL] [Abstract][Full Text] [Related]
15. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
[TBL] [Abstract][Full Text] [Related]
16. Proteomic Analysis of Protein Expression Throughout Disease Progression in a Mouse Model of Alzheimer's Disease.
Fu Y; Zhao D; Pan B; Wang J; Cui Y; Shi F; Wang C; Yin X; Zhou X; Yang L
J Alzheimers Dis; 2015; 47(4):915-26. PubMed ID: 26401771
[TBL] [Abstract][Full Text] [Related]
17. Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer's disease.
Bedse G; Romano A; Cianci S; Lavecchia AM; Lorenzo P; Elphick MR; Laferla FM; Vendemiale G; Grillo C; Altieri F; Cassano T; Gaetani S
J Alzheimers Dis; 2014; 40(3):701-12. PubMed ID: 24496074
[TBL] [Abstract][Full Text] [Related]
18. Endogenous conversion of omega-6 into omega-3 fatty acids improves neuropathology in an animal model of Alzheimer's disease.
Lebbadi M; Julien C; Phivilay A; Tremblay C; Emond V; Kang JX; Calon F
J Alzheimers Dis; 2011; 27(4):853-69. PubMed ID: 21914946
[TBL] [Abstract][Full Text] [Related]
19. Restraint stress increases neuroinflammation independently of amyloid β levels in amyloid precursor protein/PS1 transgenic mice.
Perez Nievas BG; Hammerschmidt T; Kummer MP; Terwel D; Leza JC; Heneka MT
J Neurochem; 2011 Jan; 116(1):43-52. PubMed ID: 21044080
[TBL] [Abstract][Full Text] [Related]
20. REST/NRSF-induced changes of ChAT protein expression in the neocortex and hippocampus of the 3xTg-AD mouse model for Alzheimer's disease.
Orta-Salazar E; Aguilar-Vázquez A; Martínez-Coria H; Luquín-De Anda S; Rivera-Cervantes M; Beas-Zarate C; Feria-Velasco A; Díaz-Cintra S
Life Sci; 2014 Oct; 116(2):83-9. PubMed ID: 25261598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
